Abbott | ABT - Gewinn Vor Steuern

Aktienkurs
90.16
Täglich Wechseln
-0.63 -0.69%
Monatlich
-12.36%
Jährlich
-32.12%
Q2 Prognose
89.18




Gewinn Vor Steuern Veränderung Datum
Abbott USD 2.39B 27M 2026-03
Agilent USD 442M 1000K 2025-09
AtriCure USD 2.36M 2.45M 2025-12
Baxter International USD -756M 877M 2025-12
Becton, Dickinson and Co. USD 393M 117M 2025-12
Bio-Rad Laboratories USD 929.2M 846.3M 2025-12
Boston Scientific USD 700M 238M 2025-12
Cooper Companies USD 116.8M 137.4M 2025-09
Danaher USD 1.24B 138M 2026-03
Dexcom USD 340.7M 40.7M 2025-12
Edwards Lifesciences USD 348.4M 51.8M 2025-09
Globus Medical USD 143.99M 44.18M 2025-09
Insulet USD 140.2M 17.4M 2025-12
Integra LifeSciences USD -6.82M 524.13M 2025-09
Intuitive Surgical USD 955.6M 100.4M 2025-12
J&J USD 7.82B 2.86B 2026-03
Masimo USD 74.9M 19.5M 2025-09
Medtronic USD 2.1B 224M 2025-09
Merit Medical Systems USD 51.06M 22.12M 2025-12
Pfizer USD 3.33B 290M 2025-09
Smith & Nephew USD 469M 70M 2025-12
Solventum Corp USD 511M 149M 2025-09
Stryker USD 1.7B 676M 2025-12
Tandem Diabetes Care USD -25.14M 32.58M 2025-09
Teleflex USD -438.58M 573.82M 2025-09
Terumo JPY 45.38B 578M 2025-12
Thermo Fisher Scientific USD 2.12B 295M 2025-12
Zimmer Biomet Holdings USD 98M 320.7M 2025-12